2002•Shanghai yixueRequires access

The clinical efficacy of modified COBDP chemotherapy in 24 patients with non-Hodgkin's lymphoma

Xu Qi

Abstract

Objective To study the response to COBDP chemotherapy regime in 24 patients with Non Hodgkin lymphoma. Methods Use the modified COBDP chemotherapy in 24 patients with non Hodgkin's lymphoma to observe their efficacies and side effects. Results The CR rate was 58.3% and the overall response rate was 79.1%. Conclusion COBDP regime is a practical and effective chemotherapeutie method in treatment of Non Hodgkin Lymphoma.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Lymphoma, Chemotherapy, Hodgkin lymphoma, Internal medicine, Non-Hodgkin's lymphoma, Cure rate, Oncology